Articles by Daniel Marsh
Tijuana Airport Cancellations Ease After Code-Share Audit; Traffic Trends in Focus
Tijuana Airport's flight cancellations fell after a code-share audit, but passenger trends remain key. GAP's Tijuana traffic declined 4.6% in June, while Volaris saw an 11.2% passenger increase.
Sweet v. McMahon Settlement: $12.4B Wave Mostly Debt Cancellation
The Sweet v. McMahon settlement's $12.4B wave is 94.9% debt cancellation, with only $640M in cash refunds. Strategic Education (STRA) faces recoupment risk as new claims emerge.
Social Security COLA 2027 Forecast: 3.8% Increase, $63B Payout, Medicare Premiums Rise
The Senior Citizens League forecasts a 3.8% Social Security COLA for 2027, adding $63B in annual payouts, but Medicare Part B premium hikes will offset some gains for retirees.
Markets Steady as Oil Plunges 6% and AI Earnings Loom
U.S. futures gain as oil plunges 6%, Derwent London hits a new high, and Flutter completes its NYSE transition. Investors await jobs data and AI earnings.
Nu Holdings Faces Valuation Test Ahead of Mexico Bank Launch
Nu Holdings (NU) rose 1.7% last week, but its valuation remains stretched at 22.1x trailing earnings. Mexico bank launch and rate decision loom.
SK hynix ADR Premium Narrows to 21% After Seoul Shares Surge
SK hynix shares surged 30% in Seoul, narrowing the ADR premium to ~21%. Q2 results missed estimates on HBM4 delays, but demand stays robust.
Bristol Myers Squibb at Crossroads as AstraZeneca Merger Talks Surface
Bristol Myers Squibb shares rose 5.2% last week after strong Q2 earnings, but a reported $400B merger approach from AstraZeneca puts the stock in focus Monday.
Alphabet's $119B AI Bet Puts Rebound at Risk
Alphabet's recovery faces a crucial test as it plans $119B in AI spending, potentially straining cash flow despite strong cloud growth. Markets watch AMD earnings and jobs data.
GM Stock Surges 7.5% on Strong Sales, But Valuation Gap with Ford Narrows Slowly
GM shares gained 7.5% last week, yet its valuation multiple still trails Ford's. Strong Q2 margins and raised guidance support the stock, but the gap remains.